Ocuphire Pharma - 19 Year Stock Price History | IRD
Historical daily share price chart and data for Ocuphire Pharma since 2005 adjusted for splits and dividends. The latest closing stock price for Ocuphire Pharma as of October 24, 2024 is 1.13.
- The all-time high Ocuphire Pharma stock closing price was 2880.00 on May 27, 2008.
- The Ocuphire Pharma 52-week high stock price is 3.40, which is 200.9% above the current share price.
- The Ocuphire Pharma 52-week low stock price is 1.07, which is 5.3% below the current share price.
- The average Ocuphire Pharma stock price for the last 52 weeks is 2.04.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Ocuphire Pharma Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2024 |
1.8683 |
3.0700 |
3.2650 |
1.1300 |
1.1300 |
-62.46% |
| 2023 |
3.8249 |
3.5100 |
6.3800 |
2.5900 |
3.0100 |
-14.73% |
| 2022 |
2.6176 |
4.0500 |
4.3900 |
1.8000 |
3.5300 |
-5.36% |
| 2021 |
5.6793 |
7.0000 |
13.3100 |
3.4000 |
3.7300 |
-42.53% |
| 2020 |
8.6262 |
8.0400 |
14.6400 |
3.7600 |
6.4900 |
-15.05% |
| 2019 |
19.1266 |
46.0800 |
66.2400 |
6.5600 |
7.6400 |
-82.89% |
| 2018 |
78.5294 |
100.8000 |
117.6000 |
42.7200 |
44.6400 |
-53.96% |
| 2017 |
133.3752 |
69.6480 |
322.0800 |
69.6480 |
96.9600 |
42.35% |
| 2016 |
126.9232 |
163.4880 |
191.9040 |
68.1120 |
68.1120 |
-60.91% |
| 2015 |
295.8373 |
351.9840 |
441.6000 |
174.2400 |
174.2400 |
-48.14% |
| 2014 |
423.7145 |
246.8160 |
768.0000 |
246.8160 |
336.0000 |
37.25% |
| 2013 |
194.2143 |
153.3120 |
297.6000 |
139.2000 |
244.8000 |
64.52% |
| 2012 |
217.7825 |
192.0000 |
360.0000 |
139.2000 |
148.8000 |
-17.55% |
| 2011 |
537.8537 |
542.4000 |
883.2000 |
168.0000 |
180.4800 |
-66.43% |
| 2010 |
627.1072 |
316.8000 |
1751.9999 |
316.8000 |
537.6000 |
64.71% |
| 2009 |
376.5038 |
408.0000 |
873.6000 |
225.6000 |
326.4000 |
-23.60% |
| 2008 |
883.7122 |
1080.0000 |
2879.9999 |
312.0000 |
427.2000 |
-60.43% |
| 2007 |
772.1861 |
648.0000 |
1195.2000 |
528.0000 |
1079.5200 |
66.59% |
| 2006 |
1042.5179 |
960.0000 |
2399.9999 |
528.0000 |
648.0000 |
-32.50% |
| Sector |
Industry |
Market Cap |
Revenue |
|
|
$0.000B |
$0.000B |
|
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
|
